Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease

[cafead]

via Stem Pharm Inc., a drug discovery platform company leveraging 3D neuro-immune organoids and Verge Genomics, a biotechnology company transforming drug discovery using artificial intelligence (AI) and patient tissue data, announced a collaboration to develop a disease model to validate novel targets identified by Verge for Parkinson’s disease (PD).

article source